C64 -Malignant neoplasm of kidney, except renal pelvis
Specify the patient
Sex Age Region Period Clinical stage TNMAnalysis settings
Analysis settings Change diagnosisExport options
Applied filters (reset filters)
Sex: |
Age: |
Region: |
Period:
C64 – N =71,701
Year | Stage 1 | Stage 2 | Stage 3 | Stage 4 | Not recorded | Total sum |
1982 | 3.3% | 10.9% | 8.5% | 19% | 58.4% | 860 |
1983 | 3.6% | 12.8% | 9.2% | 26.6% | 47.8% | 921 |
1984 | 3.1% | 9.7% | 9% | 26.6% | 51.6% | 977 |
1985 | 2% | 12.8% | 7.1% | 30.5% | 47.6% | 1,027 |
1986 | 3.1% | 13.5% | 8.3% | 32.4% | 42.6% | 1,138 |
1987 | 4.1% | 14.8% | 12.6% | 32.6% | 35.9% | 1,217 |
1988 | 5.1% | 16% | 10.3% | 29.6% | 39.1% | 1,258 |
1989 | 4.6% | 18.3% | 10.2% | 32.1% | 34.9% | 1,378 |
1990 | 4.2% | 17% | 12.6% | 31.4% | 34.8% | 1,455 |
1991 | 6.4% | 15.8% | 12.4% | 30% | 35.4% | 1,643 |
1992 | 7.5% | 19.9% | 14.2% | 26.1% | 32.4% | 1,715 |
1993 | 6.4% | 24% | 13.9% | 24.3% | 31.4% | 1,819 |
1994 | 8.3% | 22.9% | 13.6% | 22.9% | 32.2% | 2,312 |
1995 | 6.2% | 28.1% | 16.6% | 22.2% | 26.9% | 2,282 |
1996 | 7.4% | 30.3% | 14.8% | 19.5% | 28% | 2,400 |
1997 | 7.1% | 31.6% | 14.3% | 19.4% | 27.7% | 2,383 |
1998 | 7.6% | 30.5% | 14.8% | 20.6% | 26.5% | 2,332 |
1999 | 8.9% | 32.7% | 13.5% | 19.6% | 25.4% | 2,315 |
2000 | 12.9% | 30.7% | 11.6% | 18.1% | 26.7% | 2,381 |
2001 | 29.1% | 17.9% | 11% | 19.2% | 22.7% | 2,357 |
2002 | 32.2% | 15.7% | 11% | 19.6% | 21.6% | 2,574 |
2003 | 34.7% | 14% | 10.6% | 19.6% | 21.2% | 2,633 |
2004 | 36.3% | 15.3% | 9.4% | 19.7% | 19.3% | 2,785 |
2005 | 42.5% | 13% | 9.8% | 15.9% | 18.8% | 2,839 |
2006 | 41.8% | 11.2% | 10.8% | 18.2% | 18.1% | 2,670 |
2007 | 42.2% | 10.8% | 10% | 19.9% | 17.1% | 2,880 |
2008 | 44.7% | 11% | 11.2% | 21.6% | 11.5% | 2,900 |
2009 | 45.1% | 10.2% | 12.2% | 20.3% | 12.3% | 2,912 |
2010 | 50.2% | 10.1% | 10.7% | 19% | 10.1% | 2,935 |
2011 | 49.6% | 10.1% | 11.9% | 19.7% | 8.8% | 3,047 |
2012 | 50.3% | 10.2% | 12.2% | 18.9% | 8.3% | 3,083 |
2013 | 52.5% | 9.1% | 12.8% | 17.2% | 8.5% | 3,112 |
2014 | 54.6% | 8.4% | 12.5% | 17.3% | 7.1% | 3,161 |